Induction of ROS, p53, p21 in DEHP- and MEHP-exposed LNCaP cells-protection by selenium compounds

Food and Chemical Toxicology

Volumn 49, Issue 7, 2011, Pages 1565-1571

  Erkekoglu P ^a,b   Rachidi, W ^b   Yuzugullu O G ^c,d   Giray, B ^a   Ozturk M ^c,d   Favier, A ^b   Hincal, F ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b CEA GRENOBLE   (France)

^c BILKENT UNIVERSITY   (Turkey)

^d UNIV GRENOBLE ALPES   (France)

Author keywords

DEHP; MEHP; P21; P53; ROS; Selenium

Indexed keywords

PHTHALIC ACID 2 ETHYLHEXYL MONOESTER; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PROTEIN P21; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SELENIUM DERIVATIVE; SELENOMETHIONINE; SODIUM SELENITE;

ARTICLE; CELL PROTECTION; CELL STRAIN LNCAP; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN INDUCTION;

CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOPROTECTION; DIETHYLHEXYL PHTHALATE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; OXIDATIVE STRESS; PHTHALIC ACIDS; PLASTICIZERS; REACTIVE OXYGEN SPECIES; SELENOMETHIONINE; SODIUM SELENITE; SPERMATOGENESIS; TESTICULAR DISEASES; TESTIS; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 79957666653     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.04.001     Document Type: Article

References (61)

1. Ames B.N. Micronutrient deficiencies. A major cause of DNA damage. Ann. N.Y. Acad. Sci. 1999, 889:87-106.
2. Barlow N.J., Phillips S.L., Wallace D.G., Sar M., Gaido K.W., Foster P.M. Quantitative changes in gene expression in fetal rat testes following exposure to di(n-butyl) phthalate. Toxicol. Sci. 2003, 7:431-441.
3. Barnham K.J., Masters C.L., Bush A.I. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discovery 2004, 3:205-214.
4. Borch J., Metzdorff S.B., Vinggaard A.M., Brokken L., Dalgaard M. Mechanisms underlying the anti-androgenic effects of diethylhexyl phthalate in fetal rat testis. Toxicology 2006, 223:144-155.
5. Broadley M.R., White P.J., Bryson R.J., Meacham M.C., Bowen H.C., Johnson S.E., Hawkesford M.J., McGrath S.P., Zhao F.J., Breward N., Harriman M., Tucker M. Biofortification of UK food crops with selenium. Proc. Nutr. Soc. 2006, 65:169-181.
6. Burns T.F., El-Deiry W.S. The p53 pathway and apoptosis. J. Cell Physiol. 1999, 181:231-239.
7. Caffo O., Doglioni C., Veronese S., Bonzanini M., Marchetti A., Buttitta F., Fina P., Leek R., Morelli L., Palma P.D., Haris A.L., Barbareschi M. Prognostic value of p21 (WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up. Clin. Cancer Res. 1996, 2:1591-1599.
8. Chung L.W., Li W., Gleave M.E., Hsieh J.T., Wu H.C., Sikes R.A., Zhau H.E., Bandyk M.G., Logothetis C.J., Rubin J.S. Human prostate cancer model: roles of growth factors and extracellular matrices. J. Cell Biochem. 1992, (Suppl. 16H):99-105.
9. Clark L.C., Cantor K.P., Allaway W.H. Selenium in forage crops and cancer mortality in US counties. Arch. Environ. Health 1991, 46:37-42.
10. D'Autréaux B., Toledano M.B. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 2007, 8:813-824.
11. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825.
12. Erkekoglu, P., Zeybek, D., Giray, B., Asan, E., Hincal, F., 2011. Reproductive toxicity of di(2-ethylhexyl)phthalate in selenium-supplemented and selenium-deficient rats. Drug Chem. Toxicol., in press. doi:10.3109/01480545.2010.547499.
13. Erkekoglu P., Rachidi W., De Rosa V., Giray B., Favier A., Hincal F. Protective effect of selenium supplementation on the genotoxicity of di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate treatment in LNCaP cells. Free Radical Biol. Med. 2010, 9:559-566.
14. Erkekoglu P., Rachidi W., Yuzugullu O.G., Giray B., Favier A., Ozturk M., Hincal F. Evaluation of cytotoxicity and oxidative DNA damaging effects of di(2-ethylhexyl)phthalate (DEHP) and mono(2-ethylhexyl)phthalate (MEHP) on MA-10 Leydig cells and protection by selenium. Toxicol. Appl. Pharmacol. 2010, 248:52-62.
15. Fan J., Traore K., Li W., Amri H., Huang H., Wu C., Chen H., Zirkin B., Papadopoulos V. Molecular mechanisms mediating the effect of mono-(2-ethylhexyl)phthalate on hormone-stimulated steroidogenesis in MA-10 mouse tumor Leydig cells. Endocrinology 2010, 151:3348-3362.
16. Fang L., Lee S.W., Aaronson S.A. Comparative analysis of p73 and p53 regulation and effector functions. J. Cell Biol. 1999, 147:823-830.
17. Fei P., El-Deiry W.S. p53 and radiation responses. Oncogene 2003, 22:5774-5783.
18. Finkel T. Oxygen radicals and signaling. Curr. Opin. Cell Biol. 1998, 10:248-253.
19. Gartel A.L., Radhakrishnan S.K. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res. 2005, 65:3980-3985.
20. Gazouli M., Yao Z.X., Boujrad N., Corton J.C., Culty M., Papadopoulos V. Effect of peroxisome proliferators on Leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome proliferator-activator receptor alpha. Endocrinology 2002, 143:2571-2583.
21. Fischer J.L., Lancia J.K., Mathur A., Smith M.L. Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex. Anticancer Res. 2006, 26:899-904.
22. Hainaut P., Milner J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res. 1993, 53:4469-4473.
23. Hainaut P., Hollstein M. p53 and human cancer: the first ten thousand mutations. Adv. Cancer Res. 2000, 77:81-137.
24. Halliwell B., Cross C.E. Oxygen-derived species: their relation to human disease and environmental stress. Environ. Health Perspect. 1994, 102:5-12.
25. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75:805-816.
26. Hofseth L.J., Hussain S.P., Haris C.C. p53: 25 years after its discovery. Trends Pharmacol. Sci. 2004, 25:177-181.
27. Ip C. Lessons from basic research in selenium and cancer prevention. J. Nutr. 1998, 128:1845-1854.
28. Ishige K., Schubert D., Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radical Biol. Med. 2001, 30:433-446.
29. Jarfelt K., Dalgaard M., Hass U., Borch J., Jacobsen H., Ladefoged O. Antiandrogenic effects in male rats perinatally exposed to a mixture of di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate. Reprod. Toxicol. 2005, 19:505-515.
30. Jayaraman L., Murthy K.G., Zhu C., Curan T., Xanthoudakis S., Prives C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev. 1997, 11:558-570.
31. Kasahara E., Sato E.F., Miyoshi M., Konaka R., Hiramoto K., Sasaki J., Tokuda M., Nakano Y., Inoue M. Role of oxidative stress in germ cell apoptosis induced by di(2-ethylhexyl)phthalate. Biochem. J. 2002, 365:849-856.
32. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991, 51:6304-6311.
33. Koo H.J., Lee B.M. Estimated exposure to phthalates in cosmetics and risk assessment. J. Toxicol. Environ. Health, Part A 2004, 67:1901-1914.
34. Kuerbitz S.J., Plunkett B.S., Walsh W.V., Kastan M.B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 1992, 89:7491-7495.
35. Lane D.P., Midgley C., Hupp T. Tumour suppressor genes and molecular chaperones. Philos. Trans. R. Soc. London B, Biol. Sci. 1993, 339:69-72.
36. Letavayová L., Vlcková V., Brozmanová J. Selenium: from cancer prevention to DNA damage. Toxicology 2006, 227:1-14.
37. Loikkanen J.J., Naarala J., Savolainen K.M. Modification of glutamate-induced oxidative stress by lead: the role of extracellular calcium. Free Radical Biol. Med. 1998, 4:377-384.
38. McKee C.M., Ye Y., Richburg J.H. Testicular germ cell sensitivity to TRAIL-induced apoptosis is dependent upon p53 expression and is synergistically enhanced by DR5 agonistic antibody treatment. Apoptosis 2006, 11:2237-2250.
39. McKee R.H., Butala J.H., David R.M., Gans G. NTP center for the evaluation of risks to human reproduction reports on phthalates: addressing the data gaps. Reprod. Toxicol. 2004, 18:1-22.
40. Munsch D., Watanabe-Fukunaga R., Bourdon J.C., Nagata S., May E., Yonish-Rouach E., Reisdorf P. Human and mouse Fas(APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis. J. Biochem. 2000, 275:3867-3872.
41. Mustacich D., Powis G. Thioredoxin reductase. Biochem. J. 2000, 346:1-8.
42. Nose K. Role of reactive oxygen species in the regulation of physiological functions. Biol. Pharm. Bull. 2000, 23:897-903.
43. Oberley T.D., Zhong W., Szweda L.I., Oberley L.W. Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium. Prostate 2000, 44:144-155.
44. Ozturk M., Arslan-Ergul A., Bagislar S., Senturk S., Yuzugullu H. Senescence and immortality in hepatocellular carcinoma. Cancer Lett. 2009, 286:103-113.
45. Parks L.G., Ostby J.S., Lambright C.R., Abbott B.D., Klinefelter G.R., Barlow N.J., Gray L.E. The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol. Sci. 2000, 58:339-349.
46. Pluquet O., Hainaut P. Genotoxic and non-genotoxic pathways of p53 induction. Cancer Lett. 2001, 74:1-15.
47. Parmar D., Srivastava S.P., Singh G.B., Seth P.K. Testicular toxicity of di(2-ethylhexyl)phthalate in developing rats. Vet. Hum. Toxicol. 1995, 37:310-313.
48. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., Vogelstein B. A model for p53-induced apoptosis. Nature 1997, 389:300-305.
49. Rhodes C., Orton T.C., Pratt I.S., Batten P.L., Bratt H., Jackson S.J., Elcombe C.R. Comparative pharmacokinetics and subacute toxicity of di(2-ethylhexyl)phthalate (DEHP) in rats and marmosets: extrapolation of effects in rodents to man. Environ. Health Perspect. 1986, 65:299-307.
50. Richmond R.E., Carter J.H., Carter H.W., Daniel F.B., Deangelo A.B. Hepatocyte expression of tumor associated aldehyde dehydrogenase (ALDH-3) and p21 Ras following diethylnitrosamine (DEN) initiation and chronic exposure to di(2-ethylhexyl)phthalate (DHEP). Carcinogenesis 1996, 17:1647-1655.
51. Ryu J.Y., Whang J., Park H., Im J.Y., Kim J., Ahn M.Y., Lee J., Kim H.S., Lee B.M., Yoo S.D., Kwack S.J., Oh J.H., Park K.L., Han S.Y., Kim S.H. Di(2-ethylhexyl)phthalate induces apoptosis through peroxisome proliferators-activated receptor-gamma and ERK 1/2 activation in testis of Sprague-Dawley rats. J. Toxicol. Environ. Health, Part A 2007, 70:1296-1303.
52. Seo Y.R., Kelley M.R., Smith M.L. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc. Natl. Acad. Sci. USA 2002, 99:14548-14553.
53. Silva M.J., Samandar E., Preau J.L., Needham L.L., Calafat A.M. Urinary oxidative metabolites of di(2-ethylhexyl)phthalate in humans. Toxicology 2006, 219:22-32.
54. Sinha R., Said T.K., Medina D. Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways. Cancer Lett. 1996, 107:277-284.
55. Steinbrenner H., Sies H. Protection against reactive oxygen species by selenoproteins. Biochim. Biophys. Acta 2009, 1790:1478-1485.
56. Stewart M.S., Spallholz J.E., Neldner K.H., Pence B.C. Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radical Biol. Med. 1999, 26:42-48.
57. Ursini F., Maiorino M., Brigelius-Flohé R., Aumann K.D., Roveri A., Schomburg D., Flohé L. Diversity of glutathione peroxidases. Methods Enzymol. 1995, 252:38-53.
58. Veal E.A., Day A.M., Morgan B.A. Hydrogen peroxide sensing and signaling. Mol. Cell 2007, 26:1-14.
59. Villunger A., Michalak E.M., Coultas L., Mullauer F., Bock G., Ausserlechner M.J., Adams J.M., Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 2003, 302:1036-1038.
60. Vousden K.H., Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2002, 2:594-604.
61. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S.A., Petit P.X., Mignotte B., Kroemer G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 1995, 182:367-377.